Coral Laboratories Ltd. | Small-cap | Healthcare
₹482.70
0.17%
| Coral Laboratories Stock Comparison:
Coral Laboratories vs Sun PharmaceuticalCoral Laboratories vs Divi's LaboratoriesCoral Laboratories vs Sun Pharma AdvancedCoral Laboratories vs Aarti DrugsCoral Laboratories vs Sequent ScientificCoral Laboratories vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 281.3M
Gross Profit 135.6M 48.21%
Operating Income 21.8M 7.74%
Net Income 28.3M 10.05%

Balance Sheet Metrics

Total Assets 2.3B
Total Liabilities 282.6M
Shareholders Equity 2.0B
Debt to Equity 0.14

Cash Flow Metrics

Revenue & Profitability Trend

Coral Laboratories Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.2B821.0M778.9M732.2M952.1M
Cost of Goods Sold i530.2M403.4M492.6M426.4M537.4M
Gross Profit i619.9M417.5M286.3M305.8M414.7M
Gross Margin % i53.9%50.9%36.8%41.8%43.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-61.9M31.1M47.0M82.6M
Other Operating Expenses i210.1M79.0M83.5M82.2M81.4M
Total Operating Expenses i210.1M140.9M114.5M129.2M164.0M
Operating Income i242.3M142.6M16.3M62.2M138.7M
Operating Margin % i21.1%17.4%2.1%8.5%14.6%
Non-Operating Items
Interest Income i-33.6M17.9M17.5M20.4M
Interest Expense i976.0K2.0K3.4M1.4M425.0K
Other Non-Operating Income-----
Pre-tax Income i324.7M207.3M82.3M118.6M176.1M
Income Tax i83.1M49.4M17.8M28.1M40.6M
Effective Tax Rate % i25.6%23.8%21.6%23.7%23.0%
Net Income i241.6M157.9M64.5M90.5M135.5M
Net Margin % i21.0%19.2%8.3%12.4%14.2%
Key Metrics
EBITDA i353.5M228.7M107.1M130.3M196.2M
EPS (Basic) i-₹44.19₹18.04₹25.32₹37.94
EPS (Diluted) i-₹44.19₹18.04₹25.32₹37.94
Basic Shares Outstanding i-3572600357260035726003572600
Diluted Shares Outstanding i-3572600357260035726003572600

Income Statement Trend

Coral Laboratories Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i34.1M20.7M61.3M25.1M23.2M
Short-term Investments i1.0B257.2M238.8M217.6M190.8M
Accounts Receivable i336.4M281.9M234.2M381.1M391.6M
Inventory i98.7M151.6M125.0M183.6M216.7M
Other Current Assets188.3M1.0K211.2M1.0K-46.0K
Total Current Assets i1.8B1.5B1.2B1.3B1.3B
Non-Current Assets
Property, Plant & Equipment i217.4M232.7M242.8M227.7M204.1M
Goodwill i674.0K632.0K177.0K186.0K254.0K
Intangible Assets i-632.0K177.0K186.0K254.0K
Long-term Investments-----
Other Non-Current Assets7.3M10.6M1.0K-1.0K-2.0K
Total Non-Current Assets i529.2M518.3M508.1M590.9M389.2M
Total Assets i2.3B2.1B1.7B1.9B1.7B
Liabilities
Current Liabilities
Accounts Payable i66.2M132.4M42.1M88.0M147.8M
Short-term Debt i35.6M0060.4M62.5M
Current Portion of Long-term Debt-----
Other Current Liabilities47.4M2.7M654.0K1.5M2.6M
Total Current Liabilities i249.6M249.0M118.6M255.2M275.6M
Non-Current Liabilities
Long-term Debt i00000
Deferred Tax Liabilities i25.5M25.7M25.4M25.8M25.2M
Other Non-Current Liabilities-1.0K--2.0K2.1M
Total Non-Current Liabilities i33.0M32.8M76.9M83.3M33.3M
Total Liabilities i282.6M281.8M195.5M338.4M309.0M
Equity
Common Stock i35.7M35.7M35.7M35.7M35.7M
Retained Earnings i-1.5B1.3B1.3B1.2B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i2.0B1.8B1.5B1.6B1.4B
Key Metrics
Total Debt i35.6M0060.4M62.5M
Working Capital i1.5B1.3B1.1B1.1B1.0B

Balance Sheet Composition

Coral Laboratories Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i332.4M209.0M81.9M109.0M175.9M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-178.5M-236.0M106.7M4.0M-139.4M
Operating Cash Flow i106.4M-60.6M174.1M96.8M16.5M
Investing Activities
Capital Expenditures i-29.4M-9.9M-19.5M-55.5M-13.6M
Acquisitions i-----
Investment Purchases i-4.3M0-20.0M-20.3M0
Investment Sales i01.8M2.7M0-
Investing Cash Flow i-52.7M-21.7M-46.2M-81.9M-22.5M
Financing Activities
Share Repurchases i-----
Dividends Paid i-7.1M----
Debt Issuance i----3.4M
Debt Repayment i-----
Financing Cash Flow i-7.1M---1.0K6.8M
Free Cash Flow i-41.7M-64.6M107.2M5.4M-4.3M
Net Change in Cash i46.6M-82.3M127.9M14.9M893.0K

Cash Flow Trend

Coral Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 7.14
Forward P/E 8.30
Price to Book 0.86
Price to Sales 1.69
PEG Ratio 8.30

Profitability Ratios

Profit Margin 17.54%
Operating Margin 9.19%
Return on Equity 12.01%
Return on Assets 10.53%

Financial Health

Current Ratio 7.07
Debt to Equity 1.77
Beta 0.68

Per Share Data

EPS (TTM) ₹67.61
Book Value per Share ₹562.96
Revenue per Share ₹286.00

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
coralab1.7B7.140.8612.01%17.54%1.77
Sun Pharmaceutical 3.9T37.885.4515.08%19.29%3.26
Divi's Laboratories 1.6T70.7910.9314.64%23.89%0.03
Sun Pharma Advanced 45.5B-13.34-21.04157.88%-53.22%-1.24
Aarti Drugs 44.8B23.753.2812.28%7.80%44.92
Sequent Scientific 43.9B154.186.242.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.